ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 508

TLR3-Signaling Induces the Expression of Ro/SSA and La/SSB Autoantigens in Salivary Gland Epithelial Cells (SGECs)

Nikolaos C. Kyriakidis1, Efstathia K. Kapsogeorgou1, Vasiliki C. Gourzi1, Haralampos M. Moutsopoulos2 and Athanasios G. Tzioufas3, 1Pathophysiology, School of Medicine, National University of Athens, Greece, Athens, Greece, 2Department of Pathophysiology, School of Medicine, University of Athens, Athens, Greece, 3Pathophysiology, School of Medicine, National University of Athens, Athens, Greece

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Sjögren's Syndrome - Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Previous studies have shown that the mRNA expression levels of the Ro52/TRIM21, Ro60/TROVE2 and La/SSB intracellular autoantigens are elevated within the immunopathologic lesions of SS. High surface constitutive expression of TLR-3 has been described in long-term cultured SGECs, whereas stimulation of TLR-3 via synthetic analogues or viral RNA has been shown to be potent inducer of several immune-modulatory molecules, interferons and other cytokines, as well as apoptosis, in SGEC. Given that TLR3-mediated inflammatory responses have been shown to be negatively regulated by Ro52/TRIM21 autoantigen we sought to investigate whether TLR3 stimulation has a reciprocal effect in Ro52/TRIM21, as well as Ro60/TROVE2 and La/SSB mRNA, expression by SGECs.

Methods: SGEC lines from SS patients (n=5) and non-SS controls (n=10), were treated with the analogue of the TLR3 ligand polyinosinic:cytidylic acid (polyI:C; 5 µg/ml) and the TLR4-ligand lipopolysaccharide (LPS, 1 µg/ml, control TLR treatment) for various time-points. The expression of Ro52/TRIM21, Ro60/TROVE2 and La/SSB mRNAs was analyzed by real-time PCR at 0, 6, 12, 24, 48 and 72 hrs of treatment. The results were normalized by the expression of the HPRT1 gene and calculated by the ΔΔCT method using HeLa as calibrator. The expression of Ro52, Ro60 and La/SSB proteins was analyzed by immunoblotting, using specific antibodies. Mann-Whitney test was employed to analyze statistical significances.

Results: SGECs obtained from SS patients and controls were found to respond similarly to TLR3 signaling. The basal (constitutive) La/SSB and Ro60/TROVE2 mRNA levels were significantly upregulated following treatment of SGECs with polyI:C for 48-hrs (mean fold induction±SE: 0.86±0.18, p=0.003 and 3.29±1.75, respectively; p<0.0001 each). PolyI:C was found to be a strong inducer of Ro52/TRIM21 mRNA expression by SGECs at 6-hrs of treatment (mean fold induction of basal expression±SE: 13.12±4.5, p<0.0001). The polyI:C-induced Ro52/TRIM21 mRNA expression remained stable until 12-hrs of treatment, whereas a further increment was observed at 48-hrs of treatment (mean fold induction: 34.3±9.1 compared to basal levels, p<0.0001). The effect of polyI:C treatment in Ro52, Ro60 and La/SSB expression by SGECs  was further confirmed at the protein level by immunoblotting. Treatment with LPS was not found to affect the mRNA expression of the molecules studied (Ro52/TRIM21, Ro60/TROVE2 and La/SSB). PolyI:C or LPS treatment of HeLa cells did not show any effect on the expression levels of Ro52/TRIM21, Ro60/TROVE2 and La/SSB mRNAs.

Conclusion: Our findings indicate a reciprocal regulation of TLR3 signaling in SS-related intracellular autoantigens, and particularly Ro52 expression, by SGECs. Further investigation is needed to clarify the mechanisms involved in this regulation.


Disclosure:

N. C. Kyriakidis,
None;

E. K. Kapsogeorgou,
None;

V. C. Gourzi,
None;

H. M. Moutsopoulos,
None;

A. G. Tzioufas,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tlr3-signaling-induces-the-expression-of-rossa-and-lassb-autoantigens-in-salivary-gland-epithelial-cells-sgecs/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology